A detailed history of Tower Research Capital LLC (Trc) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,524 shares of RXST stock, worth $87,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,524
Previous 5,263 52.04%
Holding current value
$87,305
Previous $316,000 60.76%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.78 - $57.04 $111,696 - $156,232
-2,739 Reduced 52.04%
2,524 $124,000
Q2 2024

Aug 13, 2024

BUY
$50.42 - $64.29 $254,721 - $324,793
5,052 Added 2394.31%
5,263 $316,000
Q1 2024

May 15, 2024

SELL
$35.51 - $57.92 $44,849 - $73,152
-1,263 Reduced 85.69%
211 $10,000
Q4 2023

Feb 13, 2024

SELL
$20.91 - $40.9 $32,870 - $64,294
-1,572 Reduced 51.61%
1,474 $59,000
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $73,116 - $90,199
2,703 Added 788.05%
3,046 $84,000
Q2 2023

Aug 14, 2023

SELL
$16.37 - $28.9 $3,601 - $6,358
-220 Reduced 39.08%
343 $9,000
Q1 2023

May 09, 2023

SELL
$12.58 - $16.68 $2,113 - $2,802
-168 Reduced 22.98%
563 $9,000
Q4 2022

Feb 10, 2023

SELL
$9.93 - $14.2 $4,408 - $6,304
-444 Reduced 37.79%
731 $9,000
Q3 2022

Nov 10, 2022

BUY
$11.19 - $15.85 $1,913 - $2,710
171 Added 17.03%
1,175 $14,000
Q2 2022

Aug 15, 2022

SELL
$10.61 - $16.66 $254 - $399
-24 Reduced 2.33%
1,004 $14,000
Q1 2022

May 12, 2022

SELL
$8.97 - $14.03 $8,808 - $13,777
-982 Reduced 48.86%
1,028 $13,000
Q4 2021

Feb 14, 2022

BUY
$9.52 - $13.81 $12,690 - $18,408
1,333 Added 196.9%
2,010 $23,000
Q3 2021

Nov 15, 2021

BUY
$11.85 - $17.32 $8,022 - $11,725
677 New
677 $9,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $956M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.